Rotigotine

In the US, Rotigotine (rotigotine systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

• Rotigotine


• Rotigotine transdermal

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BC09

CAS registry number (Chemical Abstracts Service)

0099755-59-6

Chemical Formula

C19-H25-N-O-S

Molecular Weight

315

Therapeutic Categories

Treatment of Parkinson's disease

Dopamine agonist

Chemical Names

(-)-(S)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol (WHO)

(-)-(S)-6-[Propyl[2-(2-thienyl)ethyl]amino]-5,6,7,8-tetrahydro-1-naphtol (IUPAC)

1-Naphthalenol, 5,6,7,8-tetrahydro-5-(propyl(2-(2-thienyl)ethyl)amino)-, (S)- (CAS)

Foreign Names

• Rotigotinum (Latin)
• Rotigotin (German)
• Rotigotine (French)
• Rotigotina (Spanish)

Generic Name

• Rotigotine (OS: USAN)

Brand Names

• Neupro
  Schwarz, Austria; Schwarz, Czech Republic; Schwarz, Germany; Schwarz, Denmark; Schwarz, Spain; Schwarz, Finland; Schwarz, Greece; Schwarz, Italy; Schwarz, Netherlands; Schwarz, Slovakia; Schwarz, United States; SCHWARZ PHARMA, Norway; UCB, Australia; UCB, Ireland; UCB, Sweden; UCB Pharma, United Kingdom; UCB-Pharma, Switzerland

International Drug Name Search

Glossary

CAS	Chemical Abstracts Service
IUPAC	International Union of Pure and Applied Chemistry
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.